Drug development companies include Novoprotein, Gansu Longshen Rongfa Pharmaceutical, Carisma Therapeutics, EyePoint Pharmaceuticals, GeneOne Life Science and 520 other companies.
Novoprotein (also known as 诺唯赞) is a biotechnology company that develops and supplies recombinant proteins, reagents, and contract research and manufacturing services for biopharmaceutical and research purposes.
Gansu Longshen Rongfa Pharmaceutical (甘肃陇神戎发药业股份有限公) is a company that is engaged in the research and development, production, and sales of medicines and health food products.
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.
Knight Therapeutics is a specialty pharmaceutical company focused on acquiring, in-licensing, selling, and marketing prescription and over-the-counter pharmaceutical products.
VBL Therapeutics (also known as Notable Labs, נוטבל לאבס, בע"מ; formerly Vascular Biogenics) is a biopharmaceutical company focused on the development of treatments for cancer.